Lecturer in Management Science at the University of Strathclyde. Health economics. Policy evaluation. Risk and uncertainty analysis.
Joined July 2019
- Tweets12
- Following118
- Followers42
- Likes14
Abby Colson retweeted
A great opportunity for a fully-funded three-year PhD scholarship @StrathManSci with @arcolson and John Quigley on “Experts, Analogies & Data: Modelling Uncertainty based on Expert Understanding of Analogous Events” – see link for more info and to apply
strath.ac.uk/studywithus/pos…
Abby Colson retweeted
Our @StrathManSci colleague @arcolson will be speaking at the next session of the Glasgow Health Economics Seminar Series on Monday (22nd Nov) with @HEHTAGlasgow – looks like a really interesting session
We're looking forward to having HEHTA's @Ryan_J_Field, Dr Neil McHugh from @YunusCentreGCU & Dr @Abigail Colson @UniStrathclyde present on Monday 22 Nov. as part of our Glasgow Health Economics Seminar Series (GhESS)! gla.ac.uk/researchinstitutes…
Abby Colson retweeted
We need to pay for the social value of antibacterials, which requires updating reimbursement rules. New article from A.R. Colson, et al in Value in Health @AllianceBEAM @AndersonJames34 @LeonardColm @UKAMREnvoy valueinhealthjournal.com/art…
Congrats! Great work!
New paper, where we develop an agent-based model and explore which interventions are most effective for controlling outbreaks of covid19 infections in care homes. cambridge.org/core/journals/…
Great session from @VijayaNath1 today and lots of great discussion in the breakouts. #IAmAurora
.Thanks for being so great to work with #IAmAurora #PoliticsAndInfluence here is a helpful resource - have a great rest of the day and programme ted.com/talks/elizabeth_cox_…
How should HTA consider new antibiotics? The latest @DRIVE_AB paper from us and @CDDEP colleagues: doi.org/10.1177/238146831989… @StrathclydeOA @IMI_JU
After making the case for the potential value of expert judgements in this area, it's great to see our paper out in @PLOSONE now! @IMegiddo @CDDEP
Expert & statistical projections of resistance rates in 4 EU countries suggests stewardship and infection control will bend the curve, away from the worst case scenarios in the AMR Review journals.plos.org/plosone/ar… See this as an opportunity to deliver on national action plans
Loving the combined message of these two articles. 1. @TheEconomist: A future without antibiotics is bleak. economist.com/the-world-if/2…
2. @HarvardChanDean in @washingtonpost: We can act now to avoid that fate. washingtonpost.com/opinions/…
Exciting news from the UK!
Today we’ve launched a world-leading drive to incentivise pharmaceutical companies to develop new drugs for resistant infections (1/5) #AMR
gov.uk/government/news/devel…